Natural Alternatives International (NASDAQ:NAII) and Chromadex (NASDAQ:CDXC) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, profitability, earnings, dividends, institutional ownership, analyst recommendations and valuation.

Profitability

This table compares Natural Alternatives International and Chromadex’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Natural Alternatives International 6.53% 12.89% 10.28%
Chromadex -94.78% -108.84% -72.46%

Insider and Institutional Ownership

31.9% of Natural Alternatives International shares are owned by institutional investors. Comparatively, 18.1% of Chromadex shares are owned by institutional investors. 28.0% of Natural Alternatives International shares are owned by company insiders. Comparatively, 10.3% of Chromadex shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Analyst Ratings

This is a breakdown of recent ratings for Natural Alternatives International and Chromadex, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Natural Alternatives International 0 0 0 0 N/A
Chromadex 0 0 2 0 3.00

Chromadex has a consensus price target of $7.00, suggesting a potential upside of 50.54%. Given Chromadex’s higher possible upside, analysts plainly believe Chromadex is more favorable than Natural Alternatives International.

Earnings and Valuation

This table compares Natural Alternatives International and Chromadex’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Natural Alternatives International $132.44 million 0.66 $5.05 million N/A N/A
Chromadex $31.56 million 8.18 -$33.32 million ($0.61) -7.62

Natural Alternatives International has higher revenue and earnings than Chromadex.

Volatility and Risk

Natural Alternatives International has a beta of 0.23, meaning that its share price is 77% less volatile than the S&P 500. Comparatively, Chromadex has a beta of 1.16, meaning that its share price is 16% more volatile than the S&P 500.

Summary

Natural Alternatives International beats Chromadex on 8 of the 12 factors compared between the two stocks.

About Natural Alternatives International

Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States and internationally. It operates through two segments, Private-Label Contract Manufacturing, and Patent and Trademark Licensing. The company offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products. It also provides strategic partnering services, such as customized product formulation, clinical studies, manufacturing, marketing support, international regulatory and label law compliance, international product registration, packaging in multiple formats and labeling design, scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, packaging and delivery system design, and regulatory review. In addition, the company sells beta-alanine ingredient under the CarnoSyn and SR CarnoSyn names. It manufactures products in various forms, including capsules, tablets, chewable wafers, and powders. The company's private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer e-commerce channels, and retail stores. Natural Alternatives International, Inc. was founded in 1980 and is headquartered in Carlsbad, California.

About Chromadex

ChromaDex Corporation operates as a nutraceutical company. The company offers Nicotinamide riboside (NIAGEN), a novel form of vitamin B3 for enhancing nicotinamide adenine dinucleotide (NAD) level used for healthy aging; and Immulina, a spirulina extract and compound, which is used for improving human immune function. It also provides reference standards and fine chemicals to conduct quality control of raw materials and finished products in dietary supplements, cosmetics, food and beverages, and pharmaceutical industries. In addition, the company offers a range of consulting services, including regulatory support, product development, risk management, and litigation support. The company markets and sells its products directly in the United States and Canada; and through international distributors. ChromaDex Corporation is based in Irvine, California.

Receive News & Ratings for Natural Alternatives International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natural Alternatives International and related companies with MarketBeat.com's FREE daily email newsletter.